Literature DB >> 29035780

Long non-coding RNAs in the atherosclerotic plaque.

Serdal Arslan1, Öcal Berkan2, Torkia Lalem3, Nil Özbilüm4, Sabahattin Göksel2, Özge Korkmaz2, Nilgün Çetin1, Yvan Devaux5.   

Abstract

BACKGROUND AND AIMS: Genetic and environmental factors are important components of the development of atherosclerosis. Long non-coding RNA (lncRNAs) have emerged as regulators of multiple pathophysiological pathways in the cardiovascular system. Here, we investigated potential associations between lncRNAs and atherosclerosis.
METHODS: Tissue samples from atherosclerotic coronary artery plaques and non-atherosclerotic internal mammary artery were obtained from 20 patients during coronary artery bypass surgery. Expression levels of five lncRNAs known to be associated with coronary artery disease were measured using quantitative PCR.
RESULTS: Cyclin-dependent kinase inhibitor 2B antisense RNA 1 (ANRIL) and myocardial infarction-associated transcript (MIAT) were more expressed in the atherosclerotic arteries compared to the non-atherosclerotic arteries. Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) was less expressed in the atherosclerotic plaques. Expression levels of potassium voltage-gated channel, KQT-like subfamily, member 1 opposite strand/antisense transcript 1 (KCNQ1OT1) and hypoxia inducible factor 1A antisense RNA 2 (aHIF) were comparable between atherosclerotic and non-atherosclerotic arteries. In the atherosclerotic plaque, expression levels of MALAT1, MIAT, KCNQ1OT1 and aHIF were inversely correlated with age.
CONCLUSIONS: We report significant associations between lncRNAs and atherosclerosis. These findings support a role for lncRNAs in coronary artery disease development.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Atherosclerotic plaque; Coronary artery disease; Gene expression; Long non-coding RNAs

Mesh:

Substances:

Year:  2017        PMID: 29035780     DOI: 10.1016/j.atherosclerosis.2017.10.012

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  36 in total

1.  Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics.

Authors:  Suowen Xu; Danielle Kamato; Peter J Little; Shinichi Nakagawa; Jaroslav Pelisek; Zheng Gen Jin
Journal:  Pharmacol Ther       Date:  2018-11-13       Impact factor: 12.310

2.  Long non-coding RNA MALAT1 affects intermittent hypoxia-induced endothelial injury by regulating miR-142-3p/HMGB1.

Authors:  Meng-Xue Chen; Li-Da Chen; Jian-Chai Huang; Ai-Ming Zeng; Jie-Feng Huang; Qi-Chang Lin
Journal:  Sleep Breath       Date:  2022-01-10       Impact factor: 2.816

3.  Transcriptomic modulation in response to high-intensity interval training in monocytes of older women with type 2 diabetes.

Authors:  Jovane Hamelin Morrissette; Dominic Tremblay; Alexis Marcotte-Chénard; Farah Lizotte; Marie A Brunet; Benoit Laurent; Eléonor Riesco; Pedro Geraldes
Journal:  Eur J Appl Physiol       Date:  2022-02-19       Impact factor: 3.078

4.  Differential Expression of Long Noncoding RNAs in Patients with Coronary Artery Disease.

Authors:  Hamide Saygili; Ibrahim Bozgeyik; Onder Yumrutas; Erdal Akturk; Haydar Bagis
Journal:  Mol Syndromol       Date:  2021-08-26

5.  DLEU2 modulates proliferation, migration and invasion of platelet-derived growth factor-BB (PDGF-BB)-induced vascular smooth muscle cells (VSMCs) via miR-212-5p/YWHAZ axis.

Authors:  Zhiying Zhao; Guangming Zhang; Jing Yang; Rui Lu; Haijuan Hu
Journal:  Cell Cycle       Date:  2022-07-01       Impact factor: 5.173

Review 6.  Long non-coding RNAs regulating macrophage functions in homeostasis and disease.

Authors:  Kaitlyn R Scacalossi; Coen van Solingen; Kathryn J Moore
Journal:  Vascul Pharmacol       Date:  2018-03-13       Impact factor: 5.773

Review 7.  Non-coding RNA in Ischemic and Non-ischemic Cardiomyopathy.

Authors:  Yao Wei Lu; Da-Zhi Wang
Journal:  Curr Cardiol Rep       Date:  2018-09-26       Impact factor: 2.931

Review 8.  Regulatory Non-coding RNAs in Atherosclerosis.

Authors:  Andreas Schober; Saffiyeh Saboor Maleki; Maliheh Nazari-Jahantigh
Journal:  Handb Exp Pharmacol       Date:  2022

Review 9.  Non-coding RNAs in cardiovascular cell biology and atherosclerosis.

Authors:  Francesca Fasolo; Karina Di Gregoli; Lars Maegdefessel; Jason L Johnson
Journal:  Cardiovasc Res       Date:  2019-10-01       Impact factor: 10.787

10.  Association of polymorphisms in MALAT1 with risk of coronary atherosclerotic heart disease in a Chinese population.

Authors:  Genan Wang; Yaxiong Li; Yong Peng; Jian Tang; Hua Li
Journal:  Lipids Health Dis       Date:  2018-04-10       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.